FDA-2026-P-1636

Requests that the FDA determine whether Tovalt ODT (Zolpidem Tartrate), 5mg and 10mg Orally Disintegrating Tablets, New Drug Application 021412 had been voluntarily withdrawn from sale for safety or efficacy reasons.